Peak Experiences of Psilocybin Users and Non-Users
Christina Cummins, Jennifer Lyke
Journal of Psychoactive Drugs April 1, 2013 DOI: 10.1080/02791072.2013.785855 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 101 |
| Population | Undergraduate students and attendees at a musical event |
| Intervention | Psilocybin |
| Topics | Psilocybin Mystical experience |
| Keywords | Consciousness Hallucinogen |
| Citations | 16 |
| Key findings | 47% of psilocybin users reported their peak experience occurred while using psilocybin, and the three groups differed significantly on all dimensions of alteration of consciousness. |
Abstract
Maslow (1970) defined peak experiences as the most wonderful experiences of a person's life, which may include a sense of awe, well-being, or transcendence. Furthermore, recent research has suggested that psilocybin can produce experiences subjectively rated as uniquely meaningful and significant (Griffiths et al. 2006). It is therefore possible that psilocybin may facilitate or change the nature of peak experiences in users compared to non-users. This study was designed to compare the peak experiences of psilocybin users and non-users, to evaluate the frequency of peak experiences while under the influence of psilocybin, and to assess the perceived degree of alteration of consciousness during these experiences. Participants were recruited through convenience and snowball sampling from undergraduate classes and at a musical event. Participants were divided into three groups, those who reported a peak experience while under the influence of psilocybin (psilocybin peak experience: PPE), participants who had used psilocybin but reported their peak experiences did not occur while they were under the influence of psilocybin (non-psilocybin peak experience: NPPE), and participants who had never used psilocybin (non-user: NU). A total of 101 participants were asked to think about their peak experiences and complete a measure evaluating the degree of alteration of consciousness during that experience. Results indicated that 47% of psilocybin users reported their peak experience occurred while using psilocybin. In addition, there were significant differences among the three groups on all dimensions of alteration of consciousness. Future research is necessary to identify factors that influence the peak experiences of psilocybin users in naturalistic settings and contribute to the different characteristics of peak experiences of psilocybin users and non-users.
Comparable studies
Other cross-sectional and survey studies on mystical experience, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Of Roots and Fruits: A Comparison of Psychedelic and Nonpsychedelic Mystical Experiences Self-selected participants who reported a religious, spiritual, or mystical experience | 2016 | Cross-sectional survey | n = 739 |
| Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner Adults recruited from the MAPS website and newsletter, most reporting use of various... | 2012 | Cross-sectional survey | n = 337 |
| Peak Experiences: Some Empirical Tests Random sample of adults in the San Francisco Bay Area | 1978 | Cross-sectional survey | |
| Peak Experience Tendencies | 1982 | Cross-sectional survey | |
| Rhythmic Chanting and Mystical States across Traditions. Regular chanters across 33 countries | 2021 | Cross-sectional survey | n = 464 |
Citations in the library
Cited by 13
- Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution Frontiers in Human Neuroscience May 23, 2017
- Neural Mechanisms and Psychology of Psychedelic Ego Dissolution Pharmacological Reviews September 9, 2022
- Predictors and potentiators of psychedelic-occasioned mystical experiences Journal of Psychedelic Studies March 22, 2022
- Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use Journal of Psychoactive Drugs October 10, 2023
- Psychedelics and psychological strengths International Journal of Wellbeing February 28, 2023
and 8 more in the library
Cites 9
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
- The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans Pharmacopsychiatry July 1, 1998
- The pharmacology of psilocybin Addiction Biology October 1, 2002
- Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study Psychopharmacology March 1, 2004
and 4 more in the library